English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 20, 2026

Lord Vallance resigns as science minister ahead of cabinet reshuffle
Patient Daily | Jul 20, 2026

Phil Kerpen discusses healthcare costs and hospital consolidation on Health Policy Podcast
+ Pharmaceuticals
Patient Daily | Jul 19, 2026

Vitamin D supplementation shows no significant benefit for endometriosis pain in trial
Patient Daily | Jul 18, 2026

Webinar to address AI implementation in public pension systems on July 22
+ Pharmaceuticals
Patient Daily | Jul 17, 2026

Study finds diabetes drugs do not change risk of blinding eye condition
+ Pharmaceuticals
Patient Daily | Jul 17, 2026

Biotech IPOs return as new companies debut on public markets in 2026
+ Pharmaceuticals
Patient Daily | Jul 17, 2026

Report says India’s life sciences sector faces challenge of scaling innovation
+ Pharmaceuticals
Patient Daily | Jul 17, 2026

Study finds rise in anti-vaccine legislation linked to political polarization in US states

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation